Managing infections with novel immunotherapies: Prevention, treatment, and impact on the QoL of patients with MM episode artwork

EPISODE · Nov 9, 2021 · 8 MIN

Managing infections with novel immunotherapies: Prevention, treatment, and impact on the QoL of patients with MM

from Multiple Myeloma Hub

During the 18th International Myeloma Workshop, the Multiple Myeloma Hub spoke with Michel Delforge, UCLouvain, Louvain-la-Neuve, BE and Noopur Raje, Massachusetts General Hospital, Boston, US. In this podcast, they discuss the topic: Managing infections with novel immunotherapies: Prevention, treatment, and impact on the quality of life of patients with multiple myeloma.Raje and Delforge discuss the management of infections with novel immunotherapies, including: monoclonal antibodies, antivirals, risk of infection, intravenous immunoglobulin, and the impact of COVID-19. This podcast closely links to our latest editorial theme, in which the Multiple Myeloma Hub explores how to manage adverse events from novel agents, with our first article examining proteasome inhibitors and cardiovascular events. Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Nov 9, 2021

Embed this episode

Ready to play

Managing infections with novel immunotherapies: Prevention, treatment, and impact on the QoL of patients with MM

0:00 8:50

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Multiple Myeloma Hub?

This episode is 8 minutes long.

When was this Multiple Myeloma Hub episode published?

This episode was published on November 9, 2021.

Can I download this Multiple Myeloma Hub episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!